We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
-$10.6B
Cap. Flow %
-1.43%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.63%
2 Technology 1.89%
3 Consumer Discretionary 1.29%
4 Communication Services 0.93%
5 Healthcare 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HONE
11551
DELISTED
HarborOne Bancorp
HONE
$177K ﹤0.01%
12,640
-74,233
-85% -$1.03M
MNTSW
11552
DELISTED
Momentus Inc Warrant
MNTSW
$177K ﹤0.01%
66,381
QNST icon
11553
PUT
QuinStreet
QNST
$1.08B
$177K ﹤0.01%
10,100
-6,500
-39% -$117K
SVM
11554
CALL
Silvercorp Metals
SVM
$2.98B
$177K ﹤0.01%
46,400
+2,000
+5% +$9.05K
STSA
11555
PUT
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$177K ﹤0.01%
38,000
+1,500
+4% +$7.95K
JMP
11556
DELISTED
JMP Group LLC
JMP
$177K ﹤0.01%
23,633
+12,035
+104% +$82K
EVLV icon
11557
PUT
Evolv Technologies
EVLV
$964M
$176K ﹤0.01%
+29,300
New +$232K
FBRX icon
11558
CALL
Forte Biosciences
FBRX
$1.63B
$176K ﹤0.01%
+2,372
New +$1.31M
CBIO
11559
Crescent Biopharma
CBIO
$660M
$176K ﹤0.01%
804
+213
+36% +$45.1K
HEPA
11560
DELISTED
Hepion Pharmaceuticals
HEPA
$176K ﹤0.01%
115
-123
-52% -$197K
LAUR icon
11561
Laureate Education
LAUR
$5.38B
$176K ﹤0.01%
10,388
-31,572
-75% -$496K
PAX icon
11562
CALL
Patria Investments
PAX
$1.88B
$176K ﹤0.01%
+10,800
New +$176K
ENFY
11563
CALL
DELISTED
Enlightify Inc
ENFY
$176K ﹤0.01%
+19,400
New +$181K
OCAXU
11564
DELISTED
OCA Acquisition Corp. Unit
OCAXU
$176K ﹤0.01%
+17,460
New +$177K
HBP
11565
DELISTED
Huttig Building Products, Inc.
HBP
$176K ﹤0.01%
+33,161
New +$189K
EVGN icon
11566
Evogene
EVGN
$8.5M
$175K ﹤0.01%
6,620
+2,214
+50% +$64.6K
FLNT
11567
Fluent
FLNT
$117M
$175K ﹤0.01%
12,843
-33,977
-73% -$510K
KALV
11568
CALL
DELISTED
KalVista Pharmaceuticals
KALV
$175K ﹤0.01%
10,000
-34,800
-78% -$705K
ZKIN icon
11569
PUT
ZK International Group
ZKIN
$69.8M
$175K ﹤0.01%
8,943
-34,614
-79% -$820K
ALTY icon
11570
Global X Alternative Income ETF
ALTY
$48.5M
$174K ﹤0.01%
+13,036
New +$177K
ATXS
11571
CALL
DELISTED
Astria Therapeutics
ATXS
$174K ﹤0.01%
19,700
+15,600
+380% +$149K
RKLB icon
11572
Rocket Lab Corp
RKLB
$43.2B
$174K ﹤0.01%
10,807
-29,786
-73% -$358K
SH icon
11573
ProShares Short S&P500
SH
$824M
$174K ﹤0.01%
+2,854
New +$170K
GVP
11574
DELISTED
GSE Systems, Inc.
GVP
$174K ﹤0.01%
+11,784
New +$163K
INTZ
11575
PUT
DELISTED
INTRUSION INC NEW
INTZ
$174K ﹤0.01%
42,900
+22,700
+112% +$92.1K

Similar funds

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.